Search Results 871-880 of 17848 for Assay

  1. Lewy Body Dementia Clinical Trials - Mayo Clinic Research

    Blinded Comparison of Different Alpha-Synuclein Seeding Assays as ... assay measures of aSyn, relative to normal control subjects. Specific Aim 2.

  2. Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders

    This collaboration shows that Oxford Nanopore's technology is ready to support development and validation of assays for clinical care, and it underscores ...

  3. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC - Mayo Clinic

    * PD-L1 CPS ≥1 (by PD-L1 IHC 22C3 pharmDx assay). * Measurable disease based on RECIST 1.1. * Eastern Cooperative Oncology Group (ECOG) performance status ...

  4. Hypothyroidism (underactive thyroid) - Diagnosis and treatment - Mayo Clinic

    Treatment for hypothyroidism usually includes taking the thyroid hormone medicine levothyroxine (Levo-T, Synthroid, others) every day. This medicine is taken by ...

  5. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma - Mayo Clinic

    Undetectable viral load per standard of care assay;; Receiving antiretroviral therapy (ART/HAART) for at least 4 weeks prior to study enrollment, and have ...

  6. Cheryl L. Tran, M.D. - Mayo Clinic Faculty Profiles

    Utility of timely ADAMTS13 activity assay in management of thrombotic microangiopathy (TMA). Dr. Tran assesses the utility of timely availability of ...

  7. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

    Serum free light chain (FLC) assay; involved FLC level greater than or equal to 10 mg/dL provided the serum FLC ratio is abnormal; OR; Greater than or equal ...

  8. Focus areas - Computational Biology - Mayo Clinic Research

    Recent advances have enabled application of technologies such as assay for transposase-accessible chromatin sequencing (ATAC-seq) and RNA sequencing (RNA-seq) ...

  9. Study to Evaluate the Efficacy And Safety of Tak-861 for the Treatment of Narcolepsy With Cataplexy - Mayo Clinic

    ... assay]. Exclusion Criteria: The participant has a current medical disorder, other than narcolepsy with cataplexy, associated with EDS. The participant: (a) ...

  10. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC assay ≥ 10 mg/dL (≥ 100 mg/L) and an abnormal serum FLC ratio (< 0.26 or > 1.65). Females of childbearing ...